Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer

Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer Surg Endosc (2011) 25:1344–1345 DOI 10.1007/s00464-010-1283-8 Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer Charalambos Batsis Ioannis Makris Published online: 20 August 2010 Springer Science+Business Media, LLC 2010 As preoperative, also called neoadjuvant, chemoradiother- 35% for CT to 49% for PET. Accuracy for N staging apy has increasingly been incorporated into clinical prac- showed no significant difference (66% for EUS, 68% for tice for the multimodal treatment of resectable esophageal PET, and 63% for CT). The authors concluded that espe- cancer, there is an increased interest in how accurately the cially for T staging, EUS may have an important integrated clinical stage (cTNM) needs to be predicted before the role in the selection of surgery or neoadjuvant chemora- initiation of neoadjuvant treatment, staging (yTNM), sub- diotherapy as primary treatment. sequent surgery, and final histopathologic examination of Although the report by Choi et al. [2] is limited by the the surgical specimen (pTNM staging). retrospective analysis of data for a small number of patients Imaging technology including endoscopic ultrasonog- without randomization, it is clinically very useful for raphy (EUS), positron-emission tomography (PET), and oncologists and surgeons in daily clinical practice. Despite computed tomography (CT) currently is suggested http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Surgical Endoscopy Springer Journals

Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer

Batsis, Charalambos; Makris, Ioannis
Surgical Endoscopy , Volume 25 (4) – Aug 20, 2010
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/optimizing-locoregional-staging-in-the-preoperative-setting-of-Gsso370yDE

References (22)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Proctology; Gynecology; Hepatology; Gastroenterology; Abdominal Surgery; Surgery
ISSN
0930-2794
eISSN
1432-2218
DOI
10.1007/s00464-010-1283-8
pmid
20725745
Publisher site
See Article on Publisher Site

Abstract

Surg Endosc (2011) 25:1344–1345 DOI 10.1007/s00464-010-1283-8 Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer Charalambos Batsis Ioannis Makris Published online: 20 August 2010 Springer Science+Business Media, LLC 2010 As preoperative, also called neoadjuvant, chemoradiother- 35% for CT to 49% for PET. Accuracy for N staging apy has increasingly been incorporated into clinical prac- showed no significant difference (66% for EUS, 68% for tice for the multimodal treatment of resectable esophageal PET, and 63% for CT). The authors concluded that espe- cancer, there is an increased interest in how accurately the cially for T staging, EUS may have an important integrated clinical stage (cTNM) needs to be predicted before the role in the selection of surgery or neoadjuvant chemora- initiation of neoadjuvant treatment, staging (yTNM), sub- diotherapy as primary treatment. sequent surgery, and final histopathologic examination of Although the report by Choi et al. [2] is limited by the the surgical specimen (pTNM staging). retrospective analysis of data for a small number of patients Imaging technology including endoscopic ultrasonog- without randomization, it is clinically very useful for raphy (EUS), positron-emission tomography (PET), and oncologists and surgeons in daily clinical practice. Despite computed tomography (CT) currently is suggested

Journal

Surgical Endoscopy – Springer Journals

Published: Aug 20, 2010

There are no references for this article.